Plum SEC
Menu
Korean Market
Privacy Policy
Korean Market
Star Rating
Reset (View All)
★★★★★
★★★★
★★★
★★
★
★
★
★★
★★★
★★★★
★★★★★
All Disclosures
Search
EXCH
Icure Pharmaceutical
★★
Voluntary Withdrawal of Alzheimer's Donepezil Patch US Phase 1 Trial, Avoiding 30 Billion KRW Clinical Cost
05/22/2026, 01:19 PM
PERI
Icure Pharmaceutical
★
Icure Posts Operating Profit in Q1 but Faces Ongoing Delisting Risk
05/15/2026, 03:03 PM
PERI
Icure Pharmaceutical
★★
ICure Q1 2026: Revenue Doubles, Operating Profit Turns Positive, Delisting Risk Remains
05/15/2026, 02:42 PM
PERI
Icure Pharmaceutical
★★★
Icure: Sustained Large Net Loss and Delisting Risk - Granted Improvement Period
05/07/2026, 04:25 PM